Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

Calais Da Silva, F.E. and Goncalves, F. and Santos, A. and Kliment, J. and Calais Da Silva, F.M. and Whelan, P. and Oliver, T. and Robertson, C. (2008) Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation. European Urology Supplements, 7 (3). p. 205. ISSN 1569-9056 (http://dx.doi.org/10.1016/S1569-9056(08)60536-9)

Full text not available in this repository.Request a copy

Abstract

Introduction & Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.